Skip to main content
Premium Trial:

Request an Annual Quote

Five Japanese Pharmas License Ariadne's Pathway Software

NEW YORK (GenomeWeb News) - Ariadne said today it has recently licensed its Pathway Studio Enterprise software to five Japanese pharmaceutical companies through its distribution partner World Fusion.
 
The software is used to analyze data from microarray, proteomics, and other experiments and is supported by the company’s Resnet mammalian and plant databases.
 
Ariadne said World Fusion has been distributing its products in Japan since 2004.
 
Ariadne did not name the five pharmaceutical companies that have licensed its software.
 
Financial terms of the agreements were not released.

Filed under

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.